BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AAFS Recognizes Award-Winning Forensic Toxicologists of NMS Labs


2/19/2013 9:47:49 AM

WASHINGTON--(BUSINESS WIRE)--Three experts at NMS Labs will be recognized at the American Academy of Forensic Sciences (AAFS) meeting in Washington, D.C. Barry K. Logan, PhD, DABFT, National Director of Forensic Services, will be named President of the organization. Robert Middleberg, PhD, DABFT, DABCC-TC and Sherri Kacinko, PhD, DABFT will receive awards for their contributions to forensic toxicology. Dr. Barry Logan works with current AAFS President, Dr. Bob Barsley, and the organization’s officers to support the advancement of forensic science. With 29 years of experience in forensic toxicology, Dr. Logan’s research and casework experience centers on human performance toxicology, DUI/drugs, and postmortem toxicology. As a leader in research on impaired driving, he focuses on abused drugs and prescription medications and their impact on driver performance and crash risk. He has also led several nationwide initiatives in responding to the designer drug threat. With over 90 peer-reviewed articles in leading journals, Dr. Logan is recognized as a thought leader who makes a significant and positive difference.

Read at BioSpace.com

NMS Labs
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES